Testicular cancer is rare but primarily affects young men. To characterize the current incidence of testicular cancer in the United States, U.S. Cancer Statistics data from 1999 through 2004 were examined. Age-adjusted (2000 U.S. standard) incidence rates were calculated for seminoma and nonseminoma testicular germ cell tumors (TGCTs). Hispanic men had the largest increase in incidence rates for nonseminomas, followed by non-Hispanic White men (annual percentage change of 3.2% and 1.9%, respectively, p < .05). Nonseminomas peaked at a younger age for Hispanic, American Indian/Alaska Native (AIAN), and Asian/Pacific Islander (API) men. Whereas 9.6% of TGCTs were diagnosed at a distant stage in non-Hispanic White men, more Hispanic (16.1%), Black (13.8%), AIAN (16.8%), and API (14.9%) men with TGCTs were diagnosed with distant stage. Monitoring incidence rates for rare cancers by race/ethnicity has improved with national population-based cancer registry coverage. Disparities in diagnosis stage have implications for effective treatment of TGCTs.
American Academy of Family Physicians. (2007 ). Summary of recommendations for clinical preventive services . Revision 6.4. Leawood, KS: Author .
2.
Biggs, M.L., & Schwartz, S.M. (2004). Differences in testis cancer survival by race and ethnicity: A population-based study, 1973-1999 (United States). Cancer Causes & Control, 15, 437-444.
3.
Centers for Disease Control and Prevention. ( 1999). The National Program of Cancer Registries-Cancer surveillance system rationale and approach. Atlanta, GA: Author. Retrieved October 14, 2009, from http://www.cdc.gov/cancer/npcr/training/css.htm
4.
Centers for Disease Control and Prevention. ( 2005). Behavioral Risk Factor Surveillance System survey data . Atlanta, GA: Author. Retrieved August 24, 2009, from http://apps.nccd.cdc.gov/s_broker/htmsql.exe/weat/index.hsql
5.
Espey, D.K., Wiggins, C.L., Jim, M.A., Miller, B.A., Johnson, C.J., & Becker, T.M. ( 2008). Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer, 113(5, Suppl.), 1120-1130.
6.
Feldman, D.R., Bosl, G.J., Sheinfeld, J., & Motzer, R.J. ( 2008). Medical treatment of advanced testicular cancer. Journal of the American Medical Association, 299, 672-684.
7.
Garner, M.J., Turner, M.C., Ghadirian, P., & Krewski, D. ( 2005). Epidemiology of testicular cancer: An overview. International Journal of Cancer, 116, 331-339.
8.
Halpern, M.T., Ward, E.M., Pavluck, A.L., Schrag, N.M., Bian, J., & Chen, A.Y. ( 2008). Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: A retrospective analysis. Lancet Oncology, 9, 222-231.
9.
Harlan, L.C., Greene, A.L., Clegg, L.X., Mooney, M., Stevens, J.L., & Brown, M.L. ( 2005). Insurance status and the use of guideline therapy in the treatment of selected cancers. Journal of Clinical Oncology , 23, 9079-9088.
10.
Huyghe, E., Matsuda, T., & Thonneau, P. ( 2003). Increasing incidence of testicular cancer worldwide: A review. Journal of Urology, 170, 5-11.
Mackay, J., Jemal, A., Lee, N.C., & Parkin, D.M. ( 2006). The cancer atlas. Atlanta, GA: American Cancer Society . Retrieved June18, 2009, from http://www.cancer.org/docroot/AA/content/AA_2_5_9x_Cancer_Atlas.asp
13.
Martin, S., Ulrich, C., Munsell, M., Taylor, S., Lange, G., & Bleyer, A. ( 2007). Delays in cancer diagnosis in underinsured young adults and older adolescents. The Oncologist, 12, 816-824.
14.
McGlynn, K.A., Devesa, S.S., Graubard, B.I., & Castle, P.E. ( 2005). Increasing incidence of testicular germ cell tumors among black men in the United States. Journal of Clinical Oncology , 23, 5757-5761.
15.
McGlynn, K.A., Devesa, S.S., Sigurdson, A.J., Brown, L.M., Tsao, L., & Tarone, R.E. ( 2003). Trends in the incidence of testicular germ cell tumors in the United States. Cancer, 97, 63-70.
16.
McGlynn, K.A., Graubard, B.I., Klebanoff, M.A., & Longnecker, M.P. (2006). Risk factors for cryptorchism among populations at differing risks of testicular cancer. International Journal of Epidemiology, 35, 787-795.
17.
McKiernan, J.M., Goluboff, E.T., Liberson, G.L., Golden, R., & Fisch, H. ( 1999). Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. Journal of Urology, 162, 361-363.
18.
Molineros, J.E., Kim-Howard, X., Deshmukh, H., Jacob, C.O., Harley, J.B., & Nath, S.K. ( 2009). Admixture in Hispanic Americans: Its impact on ITGAM association and implications for admixture mapping in SLE. Genes and Immunity, 10, 539-545.
19.
Myrup, C., Westergaard, T., Schnack, T., Oudin, A., Ritz, C., & Wohlfahrt, J., et al. (2008). Testicular cancer risk in first-and second-generation immigrants to Denmark. Journal of the National Cancer Institute , 100, 41-47.
20.
NAACR Latino Research Workgroup. (2005). NAACCR guideline for enhancing Hispanic/Latino identification: Revised NAACCR Hispanic/Latino identification algorithm (NHIA v2). Springfield, IL: North American Association of Central Cancer Registries . Retrieved July 25, 2008, from http://www.naaccr.org/filesystem/pdf/NHIA%20v2%2009-21-05.pdf
21.
National Cancer Institute. (2006). Surveillance epidemiology and end results (SEER) data submission requirements . Bethesda, MD: Author. Retrieved November 18, 2008, fromhttp://seer.cancer.gov/tools/submission.html
22.
National Cancer Institute. (2008). Introduction to SEER*Stat. Bethesda, MD: Author. Retrieved November 26, 2008, from http://seer.cancer.gov/seerstat/WebHelp/seerstat.htm#Trend_Algorithms.htm
23.
National Cancer Institute. (2009). Population estimates used in NCI’s SEER*Stat software. Bethesda, MD: Author. Retrieved June 12, 2009, from http://seer.cancer.gov/popdata/methods.html
24.
Nicholson, J.L., Collins, S.R., Mahato, B., Gould, E., Schoen, C., & Rustgi, S.D. ( 2009). Rite of passage? Why young adults become uninsured and how new policies can help, 2009 update. New York: Commonwealth Fund. Retrieved August 24, 2009, from http://www.commonwealthfund.org/Content/Publications/Issue-Briefs/2009/Aug/Rite-of-Passage-Why-Young-Adults-Become-Uninsured-and-How-New-Policies-Can-Help-2009-Update.aspx
25.
Potischman, N., Troisi, R., Thadhani, R., Hoover, R.N., Dodd, K., & Davis, W.W., et al. (2005). Pregnancy hormone concentrations across ethnic groups: Implications for later cancer risk. Cancer Epidemiology, Biomarkers & Prevention, 14, 1514-1520.
26.
Purdue, M.P., Devesa, S.S., Sigurdson, A.J., & McGlynn, K.A. ( 2005). International patterns and trends in testis cancer incidence . International Journal of Cancer, 115, 822-827.
27.
Richardson, L.C., Wingo, P.A., Zack, M.M., Zahran, H.S., & King, J.B. ( 2008). Health-related quality of life in cancer survivors between ages 20 and 64 years: Population-based estimates from the Behavioral Risk Factor Surveillance System. Cancer, 112, 1380-1389.
28.
Shah, M.N., Devesa, S.S., Zhu, K., & McGlynn, K.A. ( 2007). Trends in testicular germ cell tumours by ethnic group in the United States. International Journal of Andrology, 30, 206-213.
29.
U.S. Cancer Statistics Working Group. (2008 ). United States cancer statistics: 2004 incidence and mortality . Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Retrieved July 25, 2008, from http://www.cdc.gov/cancer/npcr/uscs/
30.
U.S. Preventive Services Task Force. (2004 ). Screening for testicular cancer. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved October 6, 2008, from http://www.ahrq.gov/clinic/uspstf/uspstest.htm
31.
Weir, H.K., Marrett, L.D., & Moravan, V. ( 1999). Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996. Canadian Medical Association Journal, 160, 201-205.
